EMD-203

N/A

Report date: 2025/08/20 17:41:25

Base Information

Drug NameEMD-203
Drug Alias NameEMD-203
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionRPE65 gene transference
TargetsRetinoid isomerohydrolase
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmendobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmendobio Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A